DF
AMRX icon

Dunhill Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Dunhill Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37 Hold
3
– – ﹤0.01% 1672
2025
Q4 		$38 Buy
+3
New +$34 ﹤0.01% 1742

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dunhill Financial's AMRX Position: Q1 2026 in Review

Dunhill Financial held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 3 shares worth $37. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Dunhill Financial first reported a position in AMRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $38 in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Dunhill Financial held 3 shares of Amneal Pharmaceuticals worth $37 as of Q1 2026.
  • Dunhill Financial left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #1672 holding.
  • Dunhill Financial first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Dunhill Financial's Amneal Pharmaceuticals position peaked at $38 in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.